Viktor Janzen
Impact in
- Aging top 2%
- Genetics, Aging, and Longevity in Model Organisms
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Papers in
-
- Epigenetics and DNA Methylation 4
- Pluripotent Stem Cells Research 2
- Retinoids in leukemia and cellular processes 2
- Fibroblast Growth Factor Research 2
- Oncology 9
- Cancer Cells and Metastasis 4
- Lung Cancer Research Studies 2
- Co-authors
- David T. Scadden (8 shared papers)Heather E. Fleming (4 shared papers)Tao Cheng (1 shared paper)Yoriko Saito (2 shared papers)Norman E. Sharpless (1 shared paper)Michael T. Waring (2 shared papers)Ronald A. DePinho (1 shared paper)Randolf Forkert (1 shared paper)
- Journals
- Blood (4 papers)Cell stem cell (3 papers)PLoS ONE (2 papers)Scientific Reports (2 papers)Molecular Medicine (1 paper)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Viktor Janzen
24 papers receiving 2.0k citations
Viktor Janzen's Hit Papers
Peers
Comparison fields: 5 of 97
- Aging 118
- Hematology 454
- Genetics 303
- Molecular Biology 1.2k
- Immunology 349
Countries citing papers authored by Viktor Janzen
This map shows the geographic impact of Viktor Janzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Janzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Janzen more than expected).
Fields of papers citing papers by Viktor Janzen
This network shows the impact of papers produced by Viktor Janzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Janzen. The network helps show where Viktor Janzen may publish in the future.
Co-authors
The 25 scholars most cited alongside Viktor Janzen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a Hit paper breakdown → | 2006 | 908 |
| 2 | 2008 | 416 | |
| 3 | 2008 | 123 | |
| 4 | 2008 | 105 | |
| 5 | 2011 | 82 | |
| 6 | 2014 | 82 | |
| 7 | 2006 | 75 | |
| 8 | 2008 | 46 | |
| 9 | 2012 | 35 | |
| 10 | 2005 | 34 | |
| 11 | 2003 | 22 | |
| 12 | 2018 | 21 | |
| 13 | 2005 | 18 | |
| 14 | 2011 | 13 | |
| 15 | 2018 | 12 | |
| 16 | 2017 | 9 | |
| 17 | 2014 | 8 | |
| 18 | 2017 | 7 | |
| 19 | 2014 | 6 | |
| 20 | 2014 | 3 |
About Viktor Janzen
Viktor Janzen is a scholar working on Molecular Biology, Oncology, Hematology, Genetics and Cell Biology, having authored 24 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (4 papers), Cancer Cells and Metastasis (4 papers), Epigenetics and DNA Methylation (4 papers), Pluripotent Stem Cells Research (2 papers), Retinoids in leukemia and cellular processes (2 papers), Fibroblast Growth Factor Research (2 papers), Lung Cancer Research Studies (2 papers) and Zebrafish Biomedical Research Applications (2 papers). The work is most often cited by research in Aging (118 citations), Hematology (454 citations), Genetics (303 citations), Molecular Biology (1.2k citations) and Immunology (349 citations). Viktor Janzen has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include David T. Scadden, Heather E. Fleming, Tao Cheng, Yoriko Saito, Norman E. Sharpless, Michael T. Waring, Ronald A. DePinho, Randolf Forkert, David Dombkowski and Cristina Lo Celso. Their work appears in journals such as Blood, Cell stem cell, PLoS ONE, Scientific Reports and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.